Cargando…

Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods

PURPOSE: To determine the feasibility of predicting the rate of an axillary lymph node pathological complete response (apCR) using nomogram and machine learning methods. METHODS: A total of 247 patients with early breast cancer (eBC), who underwent neoadjuvant therapy (NAT) were included retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tianyang, Yang, Mengting, Wang, Mijia, Han, Linlin, Chen, Hong, Wu, Nan, Wang, Shan, Wang, Xinyi, Zhang, Yuting, Cui, Di, Jin, Feng, Qin, Pan, Wang, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637839/ https://www.ncbi.nlm.nih.gov/pubmed/36353547 http://dx.doi.org/10.3389/fonc.2022.1046039

Ejemplares similares

Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy
por: Wang, Wenyan, et al.
Publicado: (2022)

Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer
por: Wang, Mengshen, et al.
Publicado: (2020)

Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
por: Kim, Hyunhee, et al.
Publicado: (2021)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer
por: Kim, Jee Ye, et al.
Publicado: (2015)

CT Radiomics for Predicting Pathological Complete Response of Axillary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy: A Prospective Study
por: Li, Yan-Ling, et al.
Publicado: (2023)

A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients
por: Jin, Xi, et al.
Publicado: (2016)

A novel nomogram model of breast cancer-based imaging for predicting the status of axillary lymph nodes after neoadjuvant therapy
por: Zhang, Pengyu, et al.
Publicado: (2023)

A Clinical–Radiomics Model for Predicting Axillary Pathologic Complete Response in Breast Cancer With Axillary Lymph Node Metastases
por: Gan, Liangyu, et al.
Publicado: (2021)

Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
por: Skarping, Ida, et al.
Publicado: (2021)

Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy
por: Cao, Xiao-Shan, et al.
Publicado: (2016)

Radiomics Nomogram of DCE-MRI for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer
por: Mao, Ning, et al.
Publicado: (2020)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis
por: Wang, Li, et al.
Publicado: (2020)

Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
por: Choi, Hee Jun, et al.
Publicado: (2019)

Development of nomograms to predict axillary lymph node status in breast cancer patients
por: Chen, Kai, et al.
Publicado: (2017)

A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer
por: Shi, Wenjie, et al.
Publicado: (2022)

Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer
por: Murthy, Vijayashree, et al.
Publicado: (2021)

Incorporating ultrasound-based lymph node staging significantly improves the performance of a clinical nomogram for predicting preoperative axillary lymph node metastasis in breast cancer
por: Wang, Xiaomin, et al.
Publicado: (2023)

Corrigendum: A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer
por: Shi, Wenjie, et al.
Publicado: (2022)

MRI-Based Radiomics Nomogram: Prediction of Axillary Non-Sentinel Lymph Node Metastasis in Patients With Sentinel Lymph Node-Positive Breast Cancer
por: Qiu, Ya, et al.
Publicado: (2022)

Establishment of Simple Nomograms for Predicting Axillary Lymph Node Involvement in Early Breast Cancer
por: Zong, Qingqing, et al.
Publicado: (2020)

Nomograms for Predicting Axillary Lymph Node Status Reconciled With Preoperative Breast Ultrasound Images
por: Liu, Dongmei, et al.
Publicado: (2021)

Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial
por: Houvenaeghel, Gilles, et al.
Publicado: (2021)

Elaboration and Validation of a Nomogram Based on Axillary Ultrasound and Tumor Clinicopathological Features to Predict Axillary Lymph Node Metastasis in Patients With Breast Cancer
por: Liu, Yubo, et al.
Publicado: (2022)

A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound
por: Qiu, Si-Qi, et al.
Publicado: (2016)

A Nomogram Combined Radiomics and Kinetic Curve Pattern as Imaging Biomarker for Detecting Metastatic Axillary Lymph Node in Invasive Breast Cancer
por: Shan, Yan-na, et al.
Publicado: (2020)

Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
por: Zhu, Jiujun, et al.
Publicado: (2020)

Identification of Risk Factors Associated with Axillary Lymph Node Metastasis for Sentinel Lymph Node-Positive Breast Cancer Patients
por: He, Zhen, et al.
Publicado: (2020)

Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab
por: Ding, Jinhua, et al.
Publicado: (2017)

Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
por: Zhang, Hao, et al.
Publicado: (2023)

Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer
por: Tan, Hongna, et al.
Publicado: (2020)

Nomogram for predicting preoperative axillary lymph node status in male breast carcinoma: a SEER population-based study
por: Chen, Wenxin, et al.
Publicado: (2023)

Can targeted axillary dissection reliably advise de-escalation of completion axillary lymph node dissection?
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1–2 breast cancer with only one sentinel lymph node metastasis
por: Liu, Lei, et al.
Publicado: (2022)

A Nomogram for Identifying HR+/Her2− Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy
por: Yang, Hanzhao, et al.
Publicado: (2023)

Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection
por: Erbes, Thalia, et al.
Publicado: (2014)

Breast Axillary Lymph Node Metastasis
por: Cavalli, Luciane R., et al.
Publicado: (2011)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iv9tl8nauhp0kufv7pis4ha1sq